Evidence map›Paper›PMID 26448182›Full record

ArticlePloS one2015

Clinical and Radiographic Manifestations of Sputum Culture-Negative Pulmonary Tuberculosis.

Minh-Vu H Nguyen, Elizabeth R Jenny-Avital, Susanne Burger, Eric M Leibert, Jacqueline M Achkar

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Culture-negative TB: clinical characteristics, risk factors and treatment outcomes.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Role of Xpert MTB/RIF in Bronchoalveolar lavage fluid of sputum-scarce, suspected Pulmonary TB patients.Journal of clinical tuberculosis and other mycobacterial diseases · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minh-Vu H NguyenDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Elizabeth R Jenny-AvitalDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Susanne BurgerDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Eric M LeibertDivision of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York, United States of America.
Jacqueline M AchkarDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, United States of America.

Funding

Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Antibody Biomarkers for Early Detection of TuberculosisR01AI096213 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MAGEE, D MITCHELL · 2011 to 2012
$1.0M
Novel serological biomarker for rapid tuberculosis diagnosisR21AI105684 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ACHKAR, JACQUELINE MICHELE · 2013 to 2014
$444k
NCATS NIH HHS UL1 TR001073NCATS NIH HHS UL1TR001073NIAID NIH HHS AI096213NIAID NIH HHS R01 AI096213NIAID NIH HHS R21 AI105684
6 · The paper itself

Abstract

Intervention at the earliest possible stage of pulmonary tuberculosis (PTB) reduces morbidity for the individual and transmission for the community. We characterize the clinical and radiographic manifestations of sputum culture-negative (Cx-) PTB in order to facilitate awareness of this under recognized and likely early disease state. In this cross-sectional sub-study, we reviewed the medical records of HIV-uninfected PTB patients enrolled from 2006-2014 within the context of a TB biomarker study in New York City. Cx- PTB was defined as clinical and/or radiographic presentation consistent with PTB, three initial mycobacterial sputum cultures negative, and no evidence of other respiratory disease. Diagnosis was confirmed by clinical and radiographic improvement on antituberculous treatment and/or culture, nucleic acid, or histological confirmation from a specimen other than the initial three sputa. Cx+ PTB was defined as above but with M. tuberculosis growth in at least one of the first three sputum cultures. Demographics, symptoms, and radiographic findings on initial presentation were compared between the two groups. Of 99 subjects diagnosed with PTB, 21 met the criteria of Cx- PTB. Cx- compared to Cx+ subjects presented with a significantly lower frequency of cough (70% vs. 91%, P = 0.02), sputum production (30% vs. 64%, P < 0.01), weight loss (25% vs. 54%, P = 0.02), and frequency of cavitation on chest CT (12% vs. 68%, P < 0.01). Our findings should raise awareness that neither a positive culture nor the hallmark symptoms are invariably associated with early TB disease.

Indexed as

Mycobacterium tuberculosisAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedRadiographySputumTuberculosis, Pulmonary

Identifiers

PMID26448182
PMCPMC4598139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.